bluebird bio Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-18.04	-8.14	-4.33	-5.09	-8.26	-0.77
Depreciation & Amortization	0.68	0.4	-	-	-	-
Other Amortization	-	-	-	-	0.55	-
Asset Writedown & Restructuring Costs	6.78	6.78	2.63	-	-	-
Loss (Gain) From Sale of Investments	2.56	2.56	-	-	-0.46	-
Loss (Gain) on Equity Investments	-	-	-	0.35	0.02	-
Stock-Based Compensation	1.02	0.33	0.15	0.24	0.98	0.46
Other Operating Activities	3.92	-4.86	-0.17	-1.55	2.62	-0.04
Change in Accounts Payable	-	-	-	-	1.63	0.26
Change in Income Taxes	-	-	-	-	0.01	-0.04
Change in Other Net Operating Assets	-1.64	-0.55	0	-0.62	-0.64	-
Operating Cash Flow	-5.31	-4.07	-3.22	-6.67	-3.55	-0.12
Cash Acquisitions	-	-	-	-	3.51	-
Sale (Purchase) of Intangibles	-	-	-	-0.01	-1.6	-
Investment in Securities	0.24	0.24	-	-	-	-
Other Investing Activities	4.31	2.07	1.2	-	-22.57	-1.5
Investing Cash Flow	4.55	2.3	1.2	-0.01	-20.67	-1.5
Long-Term Debt Repaid	-	-0.29	-0.35	-	-	-
Net Debt Issued (Repaid)	-0.62	-0.29	-0.35	-	-	-
Issuance of Common Stock	0.03	-	0.03	0.34	32	13.5
Other Financing Activities	-	-	-	2	-	-0.16
Financing Cash Flow	-0.59	-0.29	-0.32	2.34	32	13.34
Foreign Exchange Rate Adjustments	-	-	-	-0.87	0.01	-
Net Cash Flow	-1.35	-2.05	-2.35	-5.21	7.79	11.72
Cash Interest Paid	0.06	0.06	-	-	-	-
Levered Free Cash Flow	-0.76	-0.22	-0.66	-	-31.06	-
Unlevered Free Cash Flow	-0.63	-0.15	-0.66	-	-31.04	-
Change in Net Working Capital	-0.45	-0.88	0.03	-	28.96	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.